- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.04. | Inspira Technologies meldet erste Einnahmen aus FDA-zugelassenem Lebenserhaltungssystem | 2 | Investing.com Deutsch | ||
| 15.04. | Inspira Technologies reports initial revenue from FDA-cleared life support system | 4 | Investing.com | ||
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 15.04. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.04. | Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems | 142 | GlobeNewswire (Europe) | RA'ANANA, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- RA'ANANA, Israel, April 15, 2025 -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 07.04. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14.03. | Inspira Technologies details strategic progress in respiratory care | 1 | Investing.com | ||
| 14.03. | Inspira Technologies informiert über strategische Fortschritte in der Atemwegsversorgung | 1 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies droht Delisting von der NASDAQ wegen Aktienkurs | 2 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies receives Nasdaq notification regarding minimum bid requirement | 3 | Seeking Alpha | ||
| 11.03. | Inspira Technologies Oxy B.H.N. reports FY results | 1 | Seeking Alpha | ||
| 11.03. | Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates | 95 | PR Newswire | Significant progress in HYLA blood sensor and INSPIRA ART core technologies
RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N.... ► Artikel lesen | |
| 11.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.03. | Inspira Technologies OXY B.H.N. Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 05.03. | Inspira Technologies OXY B.H.N. Ltd - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 04.03. | Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy | 104 | PR Newswire | Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market... ► Artikel lesen | |
| 04.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.02. | Inspira Technologies: Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections | 115 | PR Newswire | The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical... ► Artikel lesen | |
| 05.02. | EXCLUSIVE: Isreal-Based Inspira Technologies Integrates New Oxygenation Indicator Into HYLA Blood Sensor To Enhance Critical Care Monitoring | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,133 | -1,48 % | Sernova Biotherapeutics Inc: Sernova closes $4-million term loan from Navigate | ||
| ATOSSA THERAPEUTICS | 0,639 | -1,69 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,800 | -1,96 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,012 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,312 | -1,89 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,972 | +2,86 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
| VERU | 0,468 | -3,18 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VOLITIONRX | 0,480 | -0,60 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 0,360 | +0,28 % | Ekso Bionics Holdings, Inc.: Bionic P&O Chosen as First Distributor of Ekso Indego Personal Within the Orthotics & Prosthetics Industry | ||
| IMUNON | 0,795 | +2,58 % | Imunon, Inc.: IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting | ||
| BEYOND AIR | 0,190 | +3,83 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,467 | +4,60 % | Novacyt legt Termin für Finanzergebnisse 2024 fest | ||
| AROVELLA THERAPEUTICS | 0,048 | -1,03 % | AROVELLA THERAPEUTICS LIMITED: Notification regarding unquoted securities - ALA |
INSPIRA TECHNOLOGIES OXY BHN LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +3,35 % bei einem Aktienkurs von 0,620 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSPIRA TECHNOLOGIES OXY BHN LTD finden Sie auf Wallstreet Online.
